跳至主要内容
临床试验/NCT05604664
NCT05604664已完成不适用

Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Esophageal Squamous Cell Carcinoma

Yongtao Han1 个研究点 分布在 1 个国家目标入组 1,727 人开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,727
试验地点
1
主要终点
5-year survival rate of lymph nodes metastases (%) in patients

研究概览

简要总结

The goal of this observational study is to to clarify the focus of lymph node dissection during esophagectomy.. The main question[s] it aims to answer is:

  • provide a basis for accurate staging and the relationship between OS and lymph node dissection

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Pathologic findings proved ESCC (8th AJCC/UICC stage T1b-4aN0-3M0)
  • Underwent esophagecomy (two-field or three-field LN dissection)
  • The primary tumor was thoracic ESCC

排除标准

  • Located outside the thoracic
  • Patients underwent salvage or R1/R2 esophagecomy
  • The number of resected lymph nodes (RLNs) less than 15
  • With neoadjuvant therapy(NT) or salvage chemoradiotherapy(SCRT)

结局指标

主要结局

5-year survival rate of lymph nodes metastases (%) in patients

时间窗: 2010.1.1-2017.12.30

Surgical data were retrospectively collected

次要结局

未报告次要终点

研究者

发起方
Yongtao Han
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yongtao Han

Clinical Professor

Sichuan Cancer Hospital and Research Institute

研究点 (1)

Loading locations...

相似试验